García-Conde J - Search Results

1

The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen.

Menéndez P, Caballero MD, Prosper F, Del Cañizo MC, Pérez-Simón JA, Mateos MV, Nieto MJ, Corral M, Romero M, García-Conde J, Montalbán MA, San Miguel JF, Orfao A. Menéndez P, et al. Transfusion. 2002 Sep;42(9):1159-72. doi: 10.1046/j.1537-2995.2002.00190.x. Transfusion. 2002. PMID: 12430673

2

Sequential analysis of CD34+ and CD34- cell subsets in peripheral blood and leukapheresis products from breast cancer patients mobilized with SCF plus G-CSF and cyclophosphamide.

Menéndez P, Prósper F, Bueno C, Arbona C, San Miguel JF, García-Conde J, Solá C, Hornedo J, Cortés-Funes H, Orfao A. Menéndez P, et al. Leukemia. 2001 Mar;15(3):430-9. doi: 10.1038/sj.leu.2402051. Leukemia. 2001. PMID: 11237067

3

Mobilization of peripheral blood progenitor cells with a combination of cyclophosphamide, r-metHuSCF and filgrastim in patients with breast cancer previously treated with chemotherapy.

Prósper F, Solá C, Hornedo J, Arbona C, Menéndez P, Orfao A, Lluch A, Cortés-Funes H, López JJ, García-Conde J. Prósper F, et al. Leukemia. 2003 Feb;17(2):437-41. doi: 10.1038/sj.leu.2402750. Leukemia. 2003. PMID: 12592344 Clinical Trial.

4

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders.

Pérez-Simón JA, Kottaridis PD, Martino R, Craddock C, Caballero D, Chopra R, García-Conde J, Milligan DW, Schey S, Urbano-Ispizua A, Parker A, Leon A, Yong K, Sureda A, Hunter A, Sierra J, Goldstone AH, Linch DC, San Miguel JF, Mackinnon S; Spanish and United Kingdom Collaborative Groups for Nonmyeloablative Transplantation. Pérez-Simón JA, et al. Blood. 2002 Nov 1;100(9):3121-7. doi: 10.1182/blood-2002-03-0701. Blood. 2002. PMID: 12384408 Free article.

5

Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation.

Arbona C, Prosper F, Benet I, Mena F, Solano C, Garcia-Conde J. Arbona C, et al. Bone Marrow Transplant. 1998 Jul;22(1):39-45. doi: 10.1038/sj.bmt.1701293. Bone Marrow Transplant. 1998. PMID: 9678794 Clinical Trial.

6

High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group.

Caballero MD, Pérez-Simón JA, Iriondo A, Lahuerta JJ, Sierra J, Marín J, Gandarillas M, Arranz R, Zuazu J, Rubio V, Fernández de Sevilla A, Carreras E, García-Conde J, García-Laraña J, Grande C, Sureda A, Vidal MJ, Rifón J, Pérez-Equiza C, Varela R, Moraleda JM, García Ruíz JC, Albó C, Cabrera R, San Miguel JF, Conde E. Caballero MD, et al. Ann Oncol. 2003 Jan;14(1):140-51. doi: 10.1093/annonc/mdg008. Ann Oncol. 2003. PMID: 12488306 Free article.

7

Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcome.

Constans M, Sureda A, Terol MJ, Arranz R, Caballero MD, Iriondo A, Jarque I, Carreras E, Moraleda JM, Carrera D, León A, López A, Albó C, Díaz-Mediavilla J, Fernández-Abellán P, García-Ruiz JC, Hernández-Navarro F, Mataix R, Petit J, Pascual MJ, Rifón J, García-Conde J, Fernández-Rañada JM, Mateos MV, Sierra J, Conde E; GEL/TAMO Cooperative Group. Constans M, et al. Ann Oncol. 2003 May;14(5):745-51. doi: 10.1093/annonc/mdg206. Ann Oncol. 2003. PMID: 12702529 Free article.

8

Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.

Martínez-Climent JA, Comes AM, Vizcarra E, Benet I, Arbona C, Prósper F, Solano C, García Clavel B, Marugán I, Lluch A, García-Conde J. Martínez-Climent JA, et al. Bone Marrow Transplant. 2000 Jun;25(11):1203-8. doi: 10.1038/sj.bmt.1702416. Bone Marrow Transplant. 2000. PMID: 10849534

9

Prognostic significance of the immunocytochemical detection of contaminating tumor cells (CTC) in apheresis products of patients with high-risk breast cancer treated with high-dose chemotherapy and stem cell transplantation.

Solano C, Badia B, Lluch A, Marugan I, Benet I, Arbona C, Prosper F, García-Conde J. Solano C, et al. Bone Marrow Transplant. 2001 Feb;27(3):287-93. doi: 10.1038/sj.bmt.1702782. Bone Marrow Transplant. 2001. PMID: 11277176

10

Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.

Sureda A, Arranz R, Iriondo A, Carreras E, Lahuerta JJ, García-Conde J, Jarque I, Caballero MD, Ferrà C, López A, García-Laraña J, Cabrera R, Carrera D, Ruiz-Romero MD, León A, Rifón J, Díaz-Mediavilla J, Mataix R, Morey M, Moraleda JM, Altés A, López-Guillermo A, de la Serna J, Fernández-Rañada JM, Sierra J, Conde E; Grupo Español de Linformas/Transplante Autólogo de Médula Osea Spanish Cooperative Group. Sureda A, et al. J Clin Oncol. 2001 Mar 1;19(5):1395-404. doi: 10.1200/JCO.2001.19.5.1395. J Clin Oncol. 2001. PMID: 11230484

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters